单次高敏肌钙蛋白水平评估潜在急性冠脉综合征患者:1年结局
本研究比较了基于单次低水平高敏肌钙蛋白I(hs-cTnI)早期出院路径(STAT)与标准指南路径管理潜在ACS患者的效果。共纳入2255例患者,STAT组63%直接出院,标准组38%,中位住院时间缩短47分钟。12个月时两组全因死亡和心肌梗死无显著差异。
要点
- 单次低水平hs-cTnI指导的早期出院路径可增加直接出院比例并缩短住院时间。
- 该路径未增加12个月全因死亡或心肌梗死风险。
- 适用于无高危特征的潜在ACS患者。
核心结论
- 基于单次低水平hs-cTnI的早期出院临床路径与直接出院比例增加和住院时间缩短相关,且不增加1年死亡或心肌梗死风险。
研究设计与样本
- 研究纳入两个潜在ACS且无高危特征的患者队列:标准组按澳大利亚国家指南管理,STAT组按研究路径管理,共2255例(标准组1131例,STAT组1124例),平均年龄55岁,53%为男性。
- 12个月结局通过关联行政数据评估。
主要发现
- STAT组709例(63%)患者直接从急诊出院,标准组403例(38%)。
- STAT组中位住院时间缩短47分钟。
- 12个月时,未调整的全因死亡无显著差异(STAT组0.62% vs 标准组0.97%,p=0.35)。
- 12个月时,心肌梗死无显著差异(STAT组0.62% vs 标准组1.24%,p=0.13)。
临床怎么用
- 对于无高危特征的潜在ACS患者,可考虑采用基于单次低水平hs-cTnI的早期出院路径以增加直接出院并缩短住院时间,且不增加1年死亡或心肌梗死风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A pathway incorporating an option for early discharge based on a single low level of high-sensitivity cardiac troponin I (hs-cTnI) at presentation increases the proportion of patients presenting with a potential acute coronary syndrome (ACS) that can be discharged directly from the emergency department (ED), reducing length of stay without any increase in adverse events at 30 days. Here, we report the 1-year outcomes of patients managed using this pathway. METHODS: We recruited two cohorts of patients with a potential ACS, without high-risk features. The 'standard' cohort was managed according to the Australian national guidelines and the Single Troponin Accelerated Triage ('STAT') cohort was managed using the study pathway. 12-month outcomes were assessed using linked administrative data. RESULTS: Between May 2018 and October 2019, we recruited 2255 patients (1131 standard vs 1124 STAT), mean age 55 years, 53% male. 709 (63%) patients managed using the STAT pathway were discharged directly from ED, compared with 403 (38%) patients using the standard pathway, with a 47 min reduction in median hospital length of stay. At 12 months, there were no significant differences in unadjusted all-cause death (STAT 0.62% vs standard 0.97%, p=0.35) or myocardial infarction (MI) (STAT 0.62% vs standard 1.24%, p=0.13). CONCLUSIONS: A clinical pathway which incorporates early discharge based on a single low serum hs-cTnI is associated with an increased proportion of patients with a potential ACS discharged directly from the ED and reduced length of stay, without an increase in death or MI at 1 year.
引用
- Barnes, Sanfilippo, Fatovich, et al. Single high-sensitivity troponin levels to assess patients with potential acute coronary syndromes: 1-year outcomes. Heart. 2025. PMID: 40579216. doi:10.1136/heartjnl-2024-325188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。